Videos

Food and Drug Administration (FDA) Principal Deputy Commissioner Janet Woodcock and former FDA Commissioner Mark McClellan discussed COVID-19's impact on health policy, ways health agencies …

CCD Director Dr. Rochelle Walensky told a Senate committee that the Delta variant is responsible for 83% of all new COVID-19 cases. Dr. Anthony Fauci also testified about the National Instit…

Dr. Anthony Fauci, Centers for Disease Control Director Dr. Rochelle Walensky, Food and Drug Administration Acting Commissioner Dr. Janet Woodcock, and Health and Human Services Department P…

Dr. Anthony Fauci, CDC Director Dr. Rochelle Walensky, and other health officials testified at a Senate hearing on the Biden administration’s coronavirus response efforts. Senators pressed t…

The Food and Drug Administration held a briefing on the first COVID-19 vaccine approval. The vaccine, known as the Pfizer-BioNTech COVID-19 Vaccine, would be marketed as Comirnaty and be use…

Acting Food and Drug Administration Administrator Janet Woodcock testified before a House Oversight and Reform subcommittee on the department’s review into the impact of vaping. Ms. Woodcock…

Dr. Janet Woodcock, acting Food and Drug Adminiatration commissioner, testified on the agency’s fiscal year 2022 budget request before a Senate Appropriations subcommittee. Dr. Woodcock resp…

The House Energy and Commerce Subcommittee on Health held a hearing to examine ideas to modernize the Food and Drug Administration’s (FDA) regulation of over-the-counter drugs. Dr. Janet Woo…

Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also addressed senators' concerns over the lack of generic alternatives for c…

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being made on reduc…

Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a hearing on prescription drug cost increases. The CEOs …

Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in the increasin…

Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the sear…

The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration’s (FDA) drug development and approval process. Dr. Janet Woodcock, th…

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes available. At …

Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process was g…

Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process was g…

Food and Drug Administration (FDA) Commissioner Margaret Hamburg testified on the agency’s 2012 budget request.

A hearing was held on the circumstances surrounding the contamination of heparin imported from China. According to the FDA, 81 people have died after allergic reactions to the anticoagul…

The National Academies Institute of Medicine holds a meeting on the safety of FDA approved drugs. The Food and Drug Administration had asked the Institute of Medicine to assess the current s…